Table 2. Prognostic factors for overall mortality.
Unadjusted a | Cox regression, full model b | Cox regression, variable selection c | ||||
---|---|---|---|---|---|---|
HR (95% CI) | P d | HR (95% CI) | P d | HR (95% CI) | P d | |
C-stage | ||||||
C-stage 0 | Reference | <0.001 | Reference | 0.001 | Reference | <0.001 |
C-stage I | 2.80 (1.95–4.02) | 1.91 (1.28–2.85) | 1.98 (1.36–2.90) | |||
Age (years) | 1.08 (1.06–1.10) | <0.001 | 1.07 (1.05–1.09) | 0.000 | 1.07 (1.05–1.09) | <0.001 |
Gender | ||||||
Male | Reference | 0.577 | Reference | 0.612 | — | |
Female | 0.91 (0.63–1.32) | 0.94 (0.62–1.42) | ||||
BMI (kg m−2) | 0.93 (0.89–0.97) | 0.001 | 0.94 (0.89–0.99) | 0.010 | 0.94 (0.89–0.98) | 0.006 |
ASA stage | ||||||
II | Reference | <0.001 | Reference | 0.235 | — | |
III/IV | 2.58 (1.79–3.73) | 1.22 (0.77–1.95) | ||||
Cardiovascular disease | ||||||
No | Reference | <0.001 | Reference | 0.641 | — | |
Yes | 2.27 (1.50–3.42) | 1.04 (0.61–1.77) | ||||
Chronic obstructive pulmonary disease | ||||||
No | Reference | 0.003 | Reference | 0.553 | — | |
Yes | 2.21 (1.36–3.60) | 1.03 (0.60–1.78) | ||||
Chronic kidney disease | ||||||
No | Reference | 0.002 | Reference | 0.106 | Reference | 0.049 |
Yes | 4.04 (1.90–8.62) | 2.01 (0.85–4.74) | 2.28 (1.03–5.04) | |||
AJCC stage | ||||||
I | Reference | <0.001 | Reference | 0.006 | Reference | 0.004 |
II | 1.80 (1.11–2.91) | 1.36 (0.81–2.28) | 1.41 (0.85–2.32) | |||
III | 2.66 (1.70–4.17) | 2.12 (1.29–3.49) | 2.08 (1.31–3.31) | |||
Distance to anal verge | ||||||
>10 cm | Reference | 0.001 | Reference | 0.064 | Reference | 0.039 |
>5–10 cm | 1.41 (0.85–2.33) | 1.52 (0.88–2.63) | 1.48 (0.88–2.49) | |||
0–5 cm | 2.38 (1.45–3.92) | 1.97 (1.04–3.76) | 1.93 (1.11–3.37) | |||
Neoadjuvant therapy | ||||||
No | Reference | 0.199 | Reference | 0.671 | — | |
Yes | 0.79 (0.54–1.15) | 0.98 (0.62–1.56) | ||||
Operation | ||||||
Anterior resection | Reference | <0.001 | Reference | 0.117 | Reference | 0.095 |
Abd. perineal excision | 2.57 (1.64–4.04) | 1.54 (0.89–2.65) | 1.55 (0.92–2.62) | |||
Operation time (hours) | 1.02 (0.90–1.17) | 0.637 | 1.02 (0.88–1.19) | 0.612 | — | |
Resection | ||||||
R0 | Reference | 0.027 | Reference | 0.023 | Reference | 0.005 |
R1 | 5.11 (1.51–17.3) | 5.48 (1.50–20.0) | 5.65 (1.59–20.1) | |||
Adjuvant therapy | ||||||
No | Reference | 0.037 | Reference | 0.615 | — | |
Yes | 0.67 (0.45–0.99) | 0.96 (0.60–1.54) |
Abbreviations: AJCC=American Joint Committee on Cancer; ASA=American Society of Anesthesiologists.
Hazard ratios (HR) with 95% confidence intervals resulting from:
Univariate, Cox proportional hazards regression analysis for overall mortality;
Independent, full model Cox proportional hazards regression analysis for overall mortality;
Independent, backward variable selection Cox proportional hazards regression analysis for overall mortality (confirmed by forward variable selection with identical results);
P-values from likelihood ratio tests.